Perphenazine is a type of medication known as a typical antipsychotic, used predominantly in the management of symptoms related to schizophrenia such as abnormal or disturbed thought processes, diminished interest in life, and uncharacteristically strong or out-of-place emotions. This compound is also effective in controlling severe nausea and vomiting in patients. A derivative of piperazine, perphenazine is part of the phenothiazine class of antipsychotics. It works by blocking the action of dopamine, a neurotransmitter in the brain, which can mitigate the effects of certain psychiatric disorders.
Parent: Perphenazine
Parent: Perphenazine
Parent: Perphenazine
Parent: Perphenazine
Parent: Perphenazine
The manufacturing and synthesis of Perphenazine can lead to various impurities and related compounds. These may include but are not limited to geometric isomers, residual solvents, inorganic salts, unreached starting materials, degradation products, and reaction intermediates. Reliable methods of high-performance liquid chromatography (HPLC) have been developed to determine the amount of these impurities with accuracy. While the specific levels of impurities can vary, the acceptable amount is typically less than 0.1% for any individual impurity, and less than 0.2% for total impurities.
Perphenazine is also known by its brand names Trilafon and Etrafon.
Perphenazine’s mechanism of action involves the blockade of postsynaptic dopamine receptors in the brain, specifically D2 receptors. By blocking these receptors, perphenazine dampens the effects of dopamine, a neurotransmitter that is often involved in the manifestation of symptoms related to schizophrenia.
No, perphenazine is not a TCA (Tricyclic Antidepressant). It is a typical antipsychotic drug belonging to the phenothiazine class.
While perphenazine does have sedative effects, it is primarily classed as an antipsychotic. The sedative effects arise as a side effect due to the blocking of dopamine receptors in the brain.
